A clinical comparison of betamethasone 17,21-dipropionate and clobetasol propionate creams in dermatology.
In a double-blind investigation, 36 patients suffering from various steroid-reponsive dermatoses were treated twice daily for three weeks either with 0-05% betamethasone 17,21-dipropionate cream or with 0-05% clobetasol propionate cream. Results showed both products to be highly effective in terms of onset of action and efficacy and no statistical differences were found (p greater than 0-1).
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002990:Clobetasol / Q000008:administration & dosage* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D001623:Betamethasone; D002990:Clobetasol